Institut Curie;ABIVAX;UNIVERSITE DE MONTPELLIER;Centre National de la Recherche Scientifique
发明人:
申请号：
EP19157827.7
公开号：
EP3517534A1
申请日:
2010.06.14
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The present invention relates to compound (I)whereinR independently represent a hydrogen atom, a halogen atom or a group chosen among a -CN group, a hydroxyl group, a -COOR1 group, a (C1-C3)fluoroalkyl group, a (C1-C3)fluoroalkoxy group, a -NO2 group, a -NR1R2 group, a (C1-C4)alkoxy group, a phenoxy group and a (C1-C3)alkyl group； R1 and R2 are independently a hydrogen atom or a (C1-C3)alkyl group； n is 1, 2 or 3； n' is 1 or 2； R' is a hydrogen atom, a halogen atom or a group chosen among a (C1-C3)alkyl group, a hydroxyl group, a -COOR1 group, a -NO2 group, a -NR1R2 group, a morpholinyl or a morpholino group, a N-methylpiperazinyl group, a (C1-C3)fluoroalkyl group, a (C1-C4)alkoxy group and a -CN group； R" is a hydrogen atom or a (C1-C4)alkyl group, and Z is C, V is C, Y is N, X is C, T is C, U is C and W is C, for use as an agent for preventing, inhibiting or treating cancer.
